A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Letermovir (LET) Prophylaxis When Extended from 100 to 200 Days Post-Transplant in Cytomegalovirus (CMV)-Seropositive Recipients (R+) of an Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Autor:	Sanjeet Singh Dadwal, Domenico Russo, Matthias Stelljes, Michael Schmitt, Sylvain Pilorge, Valerie L. Teal, Barbara A. Haber, Charlene Bopp, Cyrus Badshah
Rok vydání:	2023
Předmět:	Transplantation Molecular Medicine Immunology and Allergy Cell Biology Hematology
Zdroj:	Transplantation and Cellular Therapy. 29:S64
ISSN:	2666-6367
DOI:	10.1016/s2666-6367(23)00145-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f55c36b71a36437b48ce493724b0442a https://doi.org/10.1016/s2666-6367(23)00145-8 Zobrazit plný text záznamu Full Text from ScienceDirect